|
Revisiting use of growth factors in myelodysplastic syndromes
|
May 2012
|
Asian Pac J Cancer Prev
|
myelodysplastic syndromes (MDS)
|
|
Revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes
|
Jun 2012
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional
|
Jun 2013
|
J Clin Oncol
|
myelodysplastic syndromes (MDS)
|
|
Retuning the immune system in myelodysplastic syndromes: from immunomodulatory approaches to vaccination strategies and non myeloablative hemopoietic cell transplant.
|
Jan 2019
|
Crit Rev Oncol Hematol
|
myelodysplastic syndromes (MDS)
|
|
Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.
|
Aug 2013
|
Bone Marrow Transplant
|
aplastic anemia
|
|
Retrospective Analysis of Prognostic Factors Associated With Response and Overall Survival by Baseline Marrow Blast Percentage in Patients With Myelodysplastic Syndromes Treated With Decitabine.
|
Jun 2013
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
|
Rethinking clinical trial endpoints in myelodysplastic syndromes.
|
Jan 2019
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Response to pre-transplant hypomethylating agents influences the outcome of allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndromes
|
Nov 2012
|
Eur J Haematol
|
myelodysplastic syndromes (MDS)
|
|
Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations.
|
Apr 2013
|
Br J Haematol
|
myelodysplastic syndromes (MDS)
|
|
Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia.
|
Jun 2014
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
